# Treatment of Coronary In-stent Restenosis (ISR) by a Sirolimus Coated or a Paclitaxel Coated Balloon

> **NCT03242096** · NA · COMPLETED · sponsor: **InnoRa GmbH** · enrollment: 50 (actual)

## Conditions studied

- Coronary Restenosis

## Interventions

- **COMBINATION_PRODUCT:** Sirolimus coated balloon
- **COMBINATION_PRODUCT:** Paclitaxel coated balloon

## Key facts

- **NCT ID:** NCT03242096
- **Lead sponsor:** InnoRa GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-21
- **Primary completion:** 2020-08-01
- **Final completion:** 2021-01-31
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2021-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03242096

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03242096, "Treatment of Coronary In-stent Restenosis (ISR) by a Sirolimus Coated or a Paclitaxel Coated Balloon". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03242096. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*